Molecule Details
| InChIKey | XNULRSOGWPFPBL-REWPJTCUSA-N |
|---|---|
| Canonical SMILES | N#Cc1ccc(N2N=C3c4ccc(C(=O)O)cc4CC[C@@H]3[C@@H]2C2CCCC2)cc1Cl |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.21 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB11814 |
|---|---|
| Drug Name | PF-03882845 |
| CAS Number | 1023650-66-9 |
| Groups | investigational |
| ATC Codes | nan |
| Description | PF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type 2 Diabetic Nephropathy. |
Categories: Benzene Derivatives Heterocyclic Compounds, Fused-Ring Hydrocarbons, Chlorinated Hydrocarbons, Halogenated Pyrazoles
Cross-references: BindingDB: 50324210 CHEMBL1215331 ChemSpider: 25053860 PubChem:46871935 PubChem:347828161 ZINC: ZINC000058583489
Target Activities (2)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P08235 | NR3C2 | Mineralocorticoid receptor | modulator | targets |